PT - JOURNAL ARTICLE AU - Kenji Fujimoto AU - Tomohiro Ishimaru AU - Seiichiro Tateishi AU - Tomohisa Nagata AU - Mayumi Tsuji AU - Hisashi Eguchi AU - Akira Ogami AU - Shinya Matsuda AU - Yoshihisa Fujino AU - for the CORoNaWork Project TI - A cross-sectional study of socioeconomic status and treatment interruption among Japanese workers during the COVID-19 pandemic AID - 10.1101/2021.02.22.21252190 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.22.21252190 4099 - http://medrxiv.org/content/early/2021/02/23/2021.02.22.21252190.short 4100 - http://medrxiv.org/content/early/2021/02/23/2021.02.22.21252190.full AB - Background The COVID-19 pandemic has caused interruptions to chronic disease and non-emergency treatment. The purpose of this study is to examine which socioeconomic status groups are most at risk of treatment interruption.Methods This cross-sectional internet monitor study was conducted on December 22–26, 2020, when Japan experienced its third wave of COVID-19 infection. Out of a total of 33,302 participants in the survey, 9510 (5392 males and 4118 females) who responded that they required regular treatment or hospital visits were included in the analysis. A multilevel logistic model nested in the prefecture of residence was used to estimate the odds ratio (OR) for treatment disruption. We examined separate multivariate models for socioeconomic factors, health factors, and lifestyle factors.Results During a period of rapid COVID-19 infection, about 11% of Japanese workers who required regular treatment experienced interruptions to their treatment. The OR of treatment interruption associated with not being married compared to being married was 1.44; manual labor work compared to desk work was 1.30; loss of employment when the COVID-19 pandemic started and continued unemployment compared to being employed over the entire pandemic period was 1.62 and 2.57, respectively; and feeling financially unstable was 2.92.Conclusion Treatment interruption is a new health inequality brought about by COVID-19 with possible medium- and long-term effects, including excess mortality, morbidity, and productivity loss due to increased presenteeism. Efforts are needed to reduce treatment interruptions among workers who require regular treatment.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.medrxiv.org/content/10.1101/2021.02.02.21249309v1 Funding StatementThis study was funded by a research grant from the University of Occupational and Environmental Health, Japan; a general incorporated foundation (Anshin Zaidan) for the development of educational materials on mental health measures for managers at small-sized enterprises; Health, Labour and Welfare Sciences Research Grants: Comprehensive Research for Women's Healthcare (H30-josei-ippan-002) and Research for the establishment of an occupational health system in times of disaster (H30-roudou-ippan-007); and scholarship donations from Chugai Pharmaceutical Co., Ltd.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the ethics committee of the University of Occupational and Environmental Health, Japan reference No. R2-079.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData not available due to ethical restrictions